The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)

Published:2010-11 Issue:2 Volume:70 Page:205-210
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Lee Jae Jin,Maeng Chi Hoon,Baek Seon Kyung,Kim Gou Young,Yoo Jee-Hong,Choi Cheon Woong,Kim Yee Hyung,Kwak Young-Tae,Kim Dae-Hyun,Lee Young Kyung,Kim Jung Bo,Kim Si-Young

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Cancer of the lung: NSCLC and SCLC;Ruckdeschel,2004

2. Korea National Statistical Office. Annual report on the cause of death statistics, Seoul, Republic of Korea; 2006.

3. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

4. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil;Reck;J Clin Oncol,2009

5. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer;Johnson;J Clin Oncol,2004

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ribonucleotide reductase subunit M1 blocks glucose catabolism via phosphorylation of pyruvate kinase M2 in human esophageal squamous cell cancer;GENES DIS;2024

2. Ribonucleotide reductase subunit M1 blocks glucose catabolism via phosphorylation of pyruvate kinase M2 in human esophageal squamous cell cancer;Genes & Diseases;2024-05

3. High‐throughput proteomic analysis of chronic inflammatory skin diseases: Psoriasis and atopic dermatitis;Experimental Dermatology;2024-04

4. Clinical use of biomarkers in the field of cytotoxic nucleoside analogues;Nucleosides, Nucleotides & Nucleic Acids;2023-10-24

5. Intratumoral bacteria are an important “accomplice” in tumor development and metastasis;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-01